Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV lignocaine for severe migraine in the emergency department
ACTRN12625001072404Phase 3Recruiting
- Sponsor
- Wide Bay Hospital and Health Service
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lidocaine and dexamethasone in migraine, sponsored by Wide Bay Hospital and Health Service. Primary endpoint: Mean change in pain score. Started Jun 2026; status: recruiting.
02
Drugs
lidocainedexamethasone
03
Conditions
migraine
Beyond the preview
Go deeper on ACTRN12625001072404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001072404.